Back to
GOLDMAN SACHS GROUP INC
CAMP7 quarters
Position history for
GOLDMAN SACHS GROUP INC's holdings in CAMP4 THERAPEUTICS CORP
Yes. Goldman Sachs holds 241,393 shares of CAMP (CAMP4 Therapeutics), worth $1.1M, as of its Q2 2026 13F filing. It increased the position from 78,345 shares in Q1 2026. Goldman Sachs has held CAMP since Q4 2025, across 3 quarterly 13F filings.
Current Value
$1.1M
Current Shares
241,393
Total Value Change
+$963,589
Total Shares Change
+223,903
Quarter-by-Quarter History
Other major holders of CAMP: Janus Henderson Group Ltd., FMR LLC, Jupiter Topco LLC